Stories Tagged as
New class of generics could save consumers, insurers billions. FDA is moving carefully.
The European Union has some 20 "biosimilar" generics on the market; the US has one.
'Biosimilar' drug launches for first time in U.S.
The new type of generic drug could reduce costs of cutting-edge medicines.